Literature DB >> 11814320

The effects of immuno-modulation on the clinical and pathological expression of postweaning multisystemic wasting syndrome.

S C Kyriakis1, K Saoulidis, S Lekkas, Ch C Miliotis, P A Papoutsis, S Kennedy.   

Abstract

Post-weaning multisystemic wasting syndrome (PMWS), primarily caused by porcine circovirus type 2 (PCV-2), is an economically important disease of pigs in many countries. A trial was designed to investigate the hypothesis that non-specific immuno-modulation can influence the clinical and pathological expression of PMWS in pigs naturally infected with PCV-2. Eighty-four pigs on a commercial pig farm were allocated to three groups of 28 pigs each, during an outbreak of PMWS. The pigs in the first group received an intramuscular injection of a vaccine against Mycoplasma hyopneumoniae (RespiSure, Pfizer, NY, USA) at each of 7 and 28 days of age, followed by an intramuscular injection of normal saline at 42 days of age. The animals in the second group received, by intramuscular injection, normal saline at 7 days of age followed by a non-specific immuno-modulating drug (Baypamun, Bayer, Leverkusen, Germany) at each of 28 and 42 days of age. The pigs in the third (control) group received an intramuscular injection of normal saline on each of 7, 28 and 42 days of age. The trial was concluded when the pigs had reached the age of 73 days. Clinical signs characteristic of PMWS developed in 42.9% of pigs inoculated with RespiSure and in 50% of pigs treated with Baypamun; six pigs from each of these groups died. Moderate to severe gross and histopathological lesions of PMWS, associated with abundant PCV-2 antigen, were seen in a wide range of tissues of pigs from these groups at the end of the trial. In contrast, only 10.7% of pigs in the control group developed clinical signs and only one died. Mild to moderate lesions and scant PCV-2 antigen were occasionally observed in tissues of control pigs at the end of the trial. This is the first study to demonstrate that non-specific stimulation of the immune system by a vaccine or an immuno-modulator drug can potentiate viral replication and increase the severity of clinical signs during an outbreak of PMWS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814320     DOI: 10.1053/jcpa.2001.0520

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  14 in total

1.  Mycoplasma hyopneumoniae bacterins and porcine circovirus type 2 (PCV2) infection: induction of postweaning multisystemic wasting syndrome (PMWS) in the gnotobiotic swine model of PCV2-associated disease.

Authors:  Steven Krakowka; John Ellis; Francis McNeilly; Cheryl Waldner; D Michael Rings; Gordon Allan
Journal:  Can Vet J       Date:  2007-07       Impact factor: 1.008

Review 2.  Transfusion transmitted virus: A review on its molecular characteristics and role in medicine.

Authors:  M Irshad; Y K Joshi; Y Sharma; I Dhar
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

3.  The role of immunostimulation in the development of postweaning multisystemic wasting syndrome in pigs under field conditions.

Authors:  Julius Haruna; Paul Hanna; Daniel Hurnik; Basil Ikede; Lisa Miller; Carmencita Yason
Journal:  Can J Vet Res       Date:  2006-10       Impact factor: 1.310

4.  Effect of granulocyte-macrophage colony-stimulating factor on post-weaning multisystemic wasting syndrome in porcine circovirus type-2-transfected piglets.

Authors:  Christophe Loizel; Philippe Blanchard; Béatrice Grasland; Daniel Dory; Aurélie Oger; Anne-Cécile Nignol; Roland Cariolet; André Jestin
Journal:  Int J Exp Pathol       Date:  2005-02       Impact factor: 1.925

5.  Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2.

Authors:  Benjamin R Trible; Andrew W Suddith; Maureen A Kerrigan; Ada G Cino-Ozuna; Richard A Hesse; Raymond R R Rowland
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

6.  Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs.

Authors:  M Fenaux; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells.

Authors:  Gerald Misinzo; Peter L Delputte; Hans J Nauwynck
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

8.  Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome.

Authors:  Renée Larochelle; Ronald Magar; Sylvie D'Allaire
Journal:  Can J Vet Res       Date:  2003-05       Impact factor: 1.310

9.  Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2.

Authors:  Cadhla Firth; Michael A Charleston; Siobain Duffy; Beth Shapiro; Edward C Holmes
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

10.  Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.

Authors:  Megan C Niederwerder; Bhupinder Bawa; Nick V L Serão; Benjamin R Trible; Maureen A Kerrigan; Joan K Lunney; Jack C M Dekkers; Raymond R R Rowland
Journal:  Clin Vaccine Immunol       Date:  2015-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.